-
Vaccines, Blood & Biologics
-
Section 8100: Communication
SOPP 8106: REVOKED: Submission of Product Approval Information For Dissemination to the Public
-
8101: Meetings
- SOPP 8101.1: Scheduling and Conduct of Regulatory Review Meetings with Sponsors and Applicants
Effective Date: May 18, 2007 - SOPP 8101.2: Scheduling and Documentation of Liaison Meetings
Effective Date: November 17, 2000 - SOPP 8101.3: Participation in or Planning of Outside Regulatory and Scientific Events
Effective Date: August 3, 2005 - SOPP 8103: Headquarters Contacts With Regulated Manufacturers During Agency Inspections
Effective Date: April 9, 1999 - SOPP 8104: Documentation of Telephone Contacts with Regulated Industry
Effective Date: May 8, 2007 - SOPP 8107: Official Correspondence with Applicants of Marketing Submissions: Addresses
Effective Date: April 16, 2001 - SOPP 8108: Distribution of "Dear Doctor" Letters
Effective Date: June 7, 2002 - SOPP 8110: Submission of Regulatory Documents to CBER
Effective Date: February 6, 2003 - SOPP 8113: Handling of Regulatory Faxes
Effective Date: October 15, 2007 - SOPP 8114: Administrative Processing of Documents Received Prior to Submitting Investigational or Marketing Applications (Pre-Application)
Effective Date: April 16, 2007 - SOPP 8115: Regulatory Site Visit Training Program
Effective Date: November 22, 2005 - SOPP 8116: Using Electronic Signatures for Investigational and Marketing Regulatory Document Concurrence/Signoff
Effective Date: July 15, 2009 - SOPP 8117: Issuing Submission Numbers in Advance of the Receipt of the Electronic Submission
Effective Date: September 24, 2007 - SOPP 8119: Use of Email for Regulatory Communications
Effective Date: February 13, 2009
-
-
-

